S Hsu Selected Research

S Hsu Research Topics

Disease

3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 08/2018
3	Neoplasms (Cancer) 02/2018 - 11/2001
2	Hyperglycemia 06/2009 - 01/2009
2	AIDS-Related Complex (ARC) 02/2008 - 02/2004
2	Body Weight (Weight, Body) 09/2004 - 05/2004
2	Carcinoma (Carcinomatosis) 06/2002 - 11/2001
2	Lichen Planus (Lichen Ruber Planus) 12/2001 - 01/2000
1	Obesity 01/2020
1	Psoriatic Arthritis 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2018
1	Wounds and Injuries (Trauma) 03/2012
1	Infections 03/2012
1	Cystic Fibrosis (Mucoviscidosis) 09/2009
1	Type 2 Diabetes Mellitus (MODY) 09/2009
1	Nasopharyngeal Carcinoma 11/2006
1	Uterine Inertia 10/2006
1	Congenital Abnormalities (Deformity) 08/2005
1	Breast Neoplasms (Breast Cancer) 11/2001
1	Mucositis 11/2001
1	Hyperpigmentation 10/2001
1	Tinea (Ringworm) 07/2001
1	Narcolepsy 03/2001
1	Sleep Wake Disorders 03/2001
1	Cataplexy 03/2001
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2001
1	Contact Dermatitis (Eczema, Contact) 05/2000
1	Bullous Pemphigoid (Pemphigoid) 01/2000

Drug/Important Bio-Agent (IBA)

3	brodalumabIBA 01/2020 - 08/2018
2	TungstenIBA 02/2008 - 02/2004
2	QuartzIBA 02/2008 - 02/2004
2	HalogensIBA 02/2008 - 02/2004
2	Thalidomide (Thalomid)FDA Link 08/2005 - 12/2001
1	Biological ProductsIBA 01/2019
1	Ustekinumab (CNTO 1275)FDA Link 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Interleukin-17 ReceptorsIBA 08/2018
1	SmokeIBA 03/2012
1	T Cell Transcription Factor 1IBA 09/2009
1	Insulin (Novolin)FDA Link 09/2009
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2009
1	Cell Cycle ProteinsIBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008
1	CytokinesIBA 02/2008
1	Celecoxib (Celebrex)FDA Link 11/2006
1	Hypnotics and Sedatives (Sedatives)IBA 08/2005
1	cobaltiprotoporphyrinIBA 09/2004
1	Blood Glucose (Blood Sugar)IBA 09/2004
1	EnzymesIBA 09/2004
1	Heme Oxygenase-1IBA 09/2004
1	SolutionsIBA 05/2004
1	ArgonIBA 02/2004
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2002
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2001
1	PolyphenolsIBA 11/2001
1	Cycloheximide (Cicloheximide)IBA 11/2001
1	Proteins (Proteins, Gene)FDA Link 11/2001
1	Capecitabine (Xeloda)FDA Link 11/2001
1	TeaIBA 11/2001
1	Chlorpromazine (Thorazine)FDA Link 10/2001
1	potassium hydroxideIBA 07/2001
1	HLA-DR Antigens (HLA-DR)IBA 03/2001
1	HLA-DQ Antigens (HLA-DQ)IBA 03/2001
1	HLA-DRB1 Chains (HLA DRB1)IBA 03/2001
1	OrexinsIBA 03/2001
1	HLA-DQB1 antigen (HLA DQB1)IBA 03/2001
1	Irritants (Vesicants)IBA 05/2000
1	Immunoglobulin G (IgG)IBA 01/2000
1	Collagen Type XVIIIBA 01/2000
1	KalininIBA 01/2000
1	AntigensIBA 01/2000
1	AutoantibodiesIBA 01/2000
1	Collagen Type VIIIBA 01/2000

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2019
2	Lasers (Laser) 02/2008 - 02/2004
1	Radiotherapy 02/2018
1	Orthopedic Procedures 03/2012
1	Transplantation 06/2009
1	Aftercare (After-Treatment) 11/2006
1	Hysterectomy 10/2006
1	Intraperitoneal Injections 09/2004